Encore Medical, Inc. (EMI)

Encore Medical will go public soon, but the exact IPO date is still unknown.
Stock Price: Pending
IPO price not available yet
Chart not available yet
Data will show when the stock starts trading.
Market Capn/a
Revenue (ttm)2.10M
Net Income (ttm)-1.58M
Shares Out 9.74M
EPS (ttm)-0.16
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Openn/a
Previous Closen/a
Day's Rangen/a
52-Week Rangen/a
Betan/a
Analystsn/a
Price Targetn/a
Earnings Daten/a

About EMI

Encore Medical is a structural heart device company dedicated to the transcatheter closure of certain cardiac defects.We develop, manufacture, and market septal occlusion products, which are small, implantable devices delivered through a catheter inserted into a major blood vessel to permanently repair certain cardiac defects. Our devices include patented technology that has been in use extensively outside of the U.S. Procedures are performed in a cardiac catheterization lab and reduce the need for open heart surgery or a lifetime of drug thera... [Read more]

Sector Healthcare
Founded 2017
Employees 16
Stock Exchange NYSEAMERICAN
Ticker Symbol EMI
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

Cardiac implant developer Encore Medical files for a $17 million IPO

Encore Medical, which makes transcatheter implants to repair cardiac defects, filed on Monday with the SEC to raise up to $17 million in an initial public offering.

26 days ago - Renaissance Capital

Encore Medical IPO Registration Document (S-1)

Encore Medical has filed to go public with an IPO on the NYSE American.

4 weeks ago - SEC